HomeCompareCNECF vs MRK

CNECF vs MRK: Dividend Comparison 2026

CNECF yields 6.67% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CNECF wins by $5.61M in total portfolio value
10 years
CNECF
CNECF
● Live price
6.67%
Share price
$1.03
Annual div
$0.07
5Y div CAGR
56.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.66M
Annual income
$4,269,210.59
Full CNECF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CNECF vs MRK

📍 CNECF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCNECFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CNECF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CNECF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CNECF
Annual income on $10K today (after 15% tax)
$566.58/yr
After 10yr DRIP, annual income (after tax)
$3,628,829.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CNECF beats the other by $3,620,500.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CNECF + MRK for your $10,000?

CNECF: 50%MRK: 50%
100% MRK50/50100% CNECF
Portfolio after 10yr
$2.86M
Annual income
$2,139,504.37/yr
Blended yield
74.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CNECF
No analyst data
Altman Z
1.4
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CNECF buys
0
MRK buys
0
No recent congressional trades found for CNECF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCNECFMRK
Forward yield6.67%2.76%
Annual dividend / share$0.07$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR56.9%32.7%
Portfolio after 10y$5.66M$56.8K
Annual income after 10y$4,269,210.59$9,798.13
Total dividends collected$5.51M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CNECF vs MRK ($10,000, DRIP)

YearCNECF PortfolioCNECF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,746$1,045.84$11,206$366.19+$540.00CNECF
2$14,369$1,801.31$12,650$502.35+$1.7KCNECF
3$18,607$3,231.32$14,407$694.19+$4.2KCNECF
4$26,044$6,135.46$16,585$967.82+$9.5KCNECF
5$40,461$12,593.19$19,342$1,363.89+$21.1KCNECF
6$71,981$28,687.58$22,913$1,947.19+$49.1KCNECF
7$151,856$74,836.68$27,662$2,823.89+$124.2KCNECF
8$393,996$231,510.15$34,159$4,173.35+$359.8KCNECF
9$1,302,359$880,783.78$43,337$6,308.80+$1.26MCNECF
10$5,662,735$4,269,210.59$56,776$9,798.13+$5.61MCNECF

CNECF vs MRK: Complete Analysis 2026

CNECFStock

Centuria Capital Group, an investment manager, markets and manages investment products primarily in Australia. It operates through Property Funds Management, Co- Investments, Developments, Property and Development Finance, Investment Bonds Management, and Corporate segments. The Property Funds Management segment manages listed and unlisted property funds. The Co-Investments segment holds interest in property funds, properties held for sale, and other liquid investments. The Developments segment engages in the management of development project and structured property developments for the commercial office, industrial, and health through residential mixed use. The Property and Development Finance segment provide real estate secured non-bank finance for land sub-division, bridging finance, development projects, and residual stock. The Investment Bonds Management segment manages benefit funds, which include a range of financial products, such as single and multi-premium investments. The Corporate segment manages reverse mortgage lending portfolio. The company was incorporated in 2000 and is headquartered in Sydney, Australia.

Full CNECF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CNECF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CNECF vs SCHDCNECF vs JEPICNECF vs OCNECF vs KOCNECF vs MAINCNECF vs JNJCNECF vs ABBVCNECF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.